Drugs Disributed by Beyond Pharma
Immunoglobulins. Human Immunoglobulin 50mg/ml. VIAL: 20 ml, 50 ml, 100 ml, 200 ml. The dose & dose regimen is depend. on the indicat. for each pt. depend. on the clin. response. Pts. bdywt. may require adjust. in underweight /overweight pts. See lit.
Replac. ther. in adult., child.,adolesc. (0-18 years) in:
Prim. immunodefic. syndr. (PID) with impair. antibod. product.
Second. immunodeficiencies (SID) in pts. who suffer from severe or recur.infect., ineffect. antimicrob. tmt. and either proven specific antibod. fail. (PSAF)* or serum IgG level of <4 g/l.
* PSAF = fail. to mount at least a 2-fold rise in IgG antibody titre to pneumococcal
polysaccharide and polypeptide antigen vaccin.
Immunomodulation in adult., and child. and adolesc. (0-18 years) in:
ITP, in pts. at high risk of bleed. or prior to surgery to correct the platelet count.
Guillain Barré syndr.
Kawasaki dis. (in conjunct. with acetylsalicyl. a.; See Lit.
Chronic inflammat. demyelinate. poliradiculoneuropathy (CIDP).
Multifoc.motor neuropath. (MMN).
C/I: Hypersens.
Pts. with selective IgA defic. who develop. antibodies to IgA, as administering an IgA contain. product can result in anaphylaxis.